EPISODE · Feb 24, 2026 · 4 MIN
今天3分钟我们来聊聊NK细胞新疗法让卵巢癌患者存活42个月
from 源于细胞BioInsid的个人播客
卵巢癌5年生存率仅40%、复发率高达80%。荷兰研究首次验证脐带血NK细胞腹腔输注安全可行，7例患者中1例存活42个月、肿瘤缩小63%，5例CA125下降，为实体瘤免疫治疗开辟新路径。前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊NK细胞新疗法让卵巢癌患者存活42个月
0:00
4:12
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 4 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on February 24, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!